MoneyHero Group to Announce Second Quarter 2024 Results
SINGAPORE, Aug. 30, 2024 (GLOBE NEWSWIRE) — MoneyHero Limited (Nasdaq:MNY) (“MoneyHero” or the “Company”), a market leading personal finance aggregation […]
AmpliTech Group’s Bookings Surpass $1M In August 2024
HAUPPAUGE, N.Y, Aug. 30, 2024 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of […]
Solidion Technology, Inc. Announces Pricing of $4 Million Private Placement
DALLAS, TEXAS, Aug. 30, 2024 (GLOBE NEWSWIRE) — Solidion Technology, Inc., (the “Company,” “Solidion,” “we,” “our” or “us”), an advanced […]
SAI.TECH Joins World Nuclear Association as New Member and to Participate in World Nuclear Symposium 2024
SINGAPORE, Aug. 30, 2024 (GLOBE NEWSWIRE) — SAI.TECH Global Corporation (“SAI.TECH” or “SAI” or the “Company”) (NASDAQ: SAI, SAITW) announces […]
FangDD Reports First Half 2024 Unaudited Financial Results
SHENZHEN, China, Aug. 30, 2024 (GLOBE NEWSWIRE) — Fangdd Network Group Ltd. (NASDAQ: DUO) (“FangDD” or “the Company”), a customer-oriented […]
SAIC Board of Directors Declares Cash Dividend
RESTON, Va., Aug. 30, 2024 (GLOBE NEWSWIRE) — Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s board […]
Gentex Announces Third Quarter 2024 Cash Dividend
ZEELAND, Mich., Aug. 30, 2024 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX), the Zeeland, Michigan-based supplier of digital vision, connected […]
DIH Appoints Haapsalu Neurological Rehabilitation Center as a DIH Center of Excellence
NORWELL, Mass. and HAAPSALU, Estonia, Aug. 30, 2024 (GLOBE NEWSWIRE) — DIH Holding US, Inc. (“DIH”)(NASDAQ:DHAI), a global provider of […]
HOOKIPA Pharma Announces Board of Directors Changes
NEW YORK and VIENNA, Aug. 30, 2024 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK) (“HOOKIPA” or the “Company”), a […]
Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
STOUGHTON, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to […]
